---
title: "Sino Biological released its first-quarter performance, with a net profit attributable to the parent company of 22.6364 million yuan, a decrease of 48.27%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237138089.md"
description: "Sino Biological released its Q1 2025 performance, with operating revenue of 155 million yuan, a year-on-year increase of 1.94%. The net profit attributable to the parent company was 22.6364 million yuan, a year-on-year decrease of 48.27%; the net profit after deducting non-recurring gains and losses was 8.5125 million yuan, a year-on-year decrease of 58.82%. The basic earnings per share were 0.1861 yuan"
datetime: "2025-04-23T09:51:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237138089.md)
  - [en](https://longbridge.com/en/news/237138089.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237138089.md)
generator: "portal-rs"
---

# Sino Biological released its first-quarter performance, with a net profit attributable to the parent company of 22.6364 million yuan, a decrease of 48.27%

According to the Zhitong Finance APP, Sino Biological (301047.SZ) released its first quarter report for 2025, with operating revenue of 155 million yuan, a year-on-year increase of 1.94%. The net profit attributable to shareholders of the listed company was 22.6364 million yuan, a year-on-year decrease of 48.27%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 8.5125 million yuan, a year-on-year decrease of 58.82%. The basic earnings per share were 0.1861 yuan

### Related Stocks

- [301047.CN](https://longbridge.com/en/quote/301047.CN.md)

## Related News & Research

- [08:02 ETMonod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays](https://longbridge.com/en/news/297041656.md)
- [Dogwood Therapeutics highlights Halneuron Phase 2b data readout timeline for chemotherapy-induced neuropathic pain program](https://longbridge.com/en/news/298049944.md)
- [14:21 ETNew Poll Shows Ed Markey's Support Slipping in Deep Blue Massachusetts](https://longbridge.com/en/news/297947167.md)
- [Syncarpha Capital solar unit faces Maryland PSC pre-hearing review for 5 MW Thurmont project](https://longbridge.com/en/news/297947626.md)
- [A GoFundMe In Support of Lindsay Clancy Nears $1.2 Million After Mistrial](https://longbridge.com/en/news/298138742.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**